This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Human Bronchial Microdialysis in Open Aortic Aneurysm Repair

This study has been completed.
Sponsor:
Collaborator:
St. Olavs Hospital
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01322295
First received: March 23, 2011
Last updated: February 12, 2017
Last verified: February 2017
March 23, 2011
February 12, 2017
March 2011
November 2011   (Final data collection date for primary outcome measure)
Cytokines in bronchial epithelial lining fluid [ Time Frame: Within 4 days of surgery ]
Same as current
Complete list of historical versions of study NCT01322295 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Human Bronchial Microdialysis in Open Aortic Aneurysm Repair
Human Bronchial Microdialysis in Open Aortic Aneurysm Repair

Elective open aortic aneurysm repair has an overall reported 30 day mortality of 2-6 percent, but in patients more than 65-70 years the mortality is reported to be more than 10 percent. The phenomenon of acute lung injury (ALI)/adult respiratory distress syndrome (ARDS) after infra renal abdominal aneurysm repair caused by ischemia-reperfusion is well established. The degree of disability varies from a light degree of acute respiratory failure to mortality for patients with the same profile of risk.

Primary aim is to develop a model that monitors inflammatory marker molecules collected from the bronchial epithelial lining fluid by microdialysis. The method with examination of the bronchial epithelial lining fluid by microdialysis and analysis of multiple inflammation markers as previously done by the investigators group.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients assigned for elective open aortic surgery are enrolled by invitation
Acute Lung Injury
Not Provided
Not Provided
Tyvold SS, Solligård E, Gunnes S, Lyng O, Johannisson A, Grønbech JE, Aadahl P. Bronchial microdialysis of cytokines in the epithelial lining fluid in experimental intestinal ischemia and reperfusion before onset of manifest lung injury. Shock. 2010 Nov;34(5):517-24. doi: 10.1097/SHK.0b013e3181dfc430.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
16
December 2011
November 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients assigned for elective open aortic surgery

Exclusion Criteria:

  • Moderate to severe COPD
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01322295
2010/1649a
No
Not Provided
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
St. Olavs Hospital
Principal Investigator: Erik Solligård, md phd Norwegian University of Science and Technology
Norwegian University of Science and Technology
February 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP